Duration: It is expected that your participation will last approximately 10 weeks, including the Follow-Up Period. The Treatment Period for this study is approximately 28 days.
Procedures and Activities: During this study, you will be required to visit the study site at least 8 times, not including the Screening Period. Two of these visits include inpatient stays (overnight) for 5 days and 4 nights. For the first inpatient stay, you will be admitted to the Center for Human Phenomic Science (CHPS) starting 2 days prior to the date of the first dose of study drug (the Baseline Period) through Day 3 of the Treatment Period. The second inpatient stay will start near the end of the Treatment Period during which you will be admitted to the inpatient unit starting on Day 26 through Day 30.
How understandable was the trial content above?
Hard to understand
Easy to understand
